. Author manuscript; available in PMC: 2019 Aug 1.

Published in final edited form as: J Allergy Clin Immunol. 2017 Dec 19;141(4):1459–1467.e2. doi: 10.1016/j.jaci.2017.09.043

Table 2.

Baseline asthma-related characteristics by BMI status

	BMI-percentile
	10–84^th (N=492)	≥ 85^th (N=244)	p-value
Age at enrollment in months, mean (SD)	38.9 (9.1)	39.6 (9.9)	0.45
Age at diagnosis in months, mean (SD)	19.4 (11.4)	18.4 (11.2)	0.31
Weight in kg, mean (SD)	15.0 (2.1)	18.4 (3.7)	<0.0001
Female	193 (39.2%)	78 (32%)	0.055
Race
Non-Hispanic White	223 (45.3)	89 (36.5)	0.0223
Non-Hispanic Black	95 (19.3)	45 (18.4)	0.78
Hispanic	108 (22.0)	81 (33.2)	0.0010
Other Race	66 (13.4)	29 (11.9)	0.56

Tobacco smoke exposure	188 (38.3)	103 (42.4)	0.16
Pets in Home	225 (45.7)	109 (44.7)	0.79
Positive Aeroallergen Test	278 (57.3)	126 (52.3)	0.20
Child ever have eczema	279 (56.7)	129 (52.9)	0.98
IgE (kU/L)^*	64.5 (21.6, 202.0)	49.0 (16.1, 161.5)	0.060
Blood eosinophils %^*	3.7 (2.0, 6.1)	3.0 (1.9, 5.0)	0.0068

Average SFDs per week, mean (SD)	5.3 (1.8)	5.3 (1.8)	0.62
Average SABA puffs per week^*	0.4 (0.0, 1.4)	0.0 (0.0, 1.3)	0.095
Urgent/ED visit in the past year	310 (63)	161 (66)	0.43
Hospitalized in the past year	60 (12.2)	45 (18.4)	0.0226

Values represent counts (%) unless noted. BMI – body mass index, SFD – symptom free days, SABA – short-acting beta-agonist, ED – emergency department.

^{* -}

Wilcoxon test